Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

At Ford Field on Thursday, Amon-Ra St. Brown and the Detroit Lions (7-5) face Javonte Williams and the Dallas Cowboys (6-5-1) in a matchup featuring two of the brightest stars in the NFL, beginning at ...

Your credit score is the key to your financial future: It can determine whether you get approved for a credit card, car loan or mortgage, and what interest rate you'll pay. In some cases, your score ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Payments for the ANCHOR program — short for Affordable New Jersey Communities for Homeowners and Renters — may have begun rolling out Sept. 15, but there's still time to apply for your check. Recent ...

The acquisition brings runtime protection, continuous red teaming, and multilingual defenses into Check Point’s Infinity platform as enterprises confront risks from LLMs, agents, and generative AI ...

Windows 11 is testing a network speed test that you run from the taskbar. The speed test icon takes you to the Bing website. For now, you need a Windows 11 Insider build to use the feature. Now ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...

The only way to know your smoke alarm is functioning and ready (except for letting your turkey burn in the oven) is to test it. And tests don't just confirm that smoke detectors have power -- they can ...

Palantir's stock is up nearly 10 % month-to-date and has gone even higher year-to-date, as bullish sentiment surges ahead of its second quarter earnings. Tempus AI shares, currently at about $64, have ...